Carlsmed, Inc.
CARL
$16.28
$0.070.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 13.07M | 12.08M | 10.19M | 6.59M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 13.07M | 12.08M | 10.19M | 6.59M | |
| Cost of Revenue | 3.15M | 3.21M | 2.55M | 1.79M | |
| Gross Profit | 9.93M | 8.87M | 7.64M | 4.80M | |
| SG&A Expenses | 14.52M | 11.21M | 10.21M | 8.54M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 22.11M | 18.59M | 15.91M | 14.37M | |
| Operating Income | -9.04M | -6.50M | -5.72M | -7.78M | |
| Income Before Tax | -8.53M | -6.77M | -5.73M | -7.81M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -8.53M | -6.77M | -5.73M | -7.81M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -8.53M | -6.77M | -5.73M | -7.81M | |
| EBIT | -9.04M | -6.50M | -5.72M | -7.78M | |
| EBITDA | -8.95M | -6.44M | -5.68M | -7.74M | |
| EPS Basic | -0.40 | -1.47 | -1.47 | -2.06 | |
| Normalized Basic EPS | -0.25 | -0.92 | -0.83 | -1.19 | |
| EPS Diluted | -0.40 | -1.47 | -1.47 | -2.06 | |
| Normalized Diluted EPS | -0.25 | -0.92 | -0.83 | -1.19 | |
| Average Basic Shares Outstanding | 21.08M | 4.59M | 4.30M | 4.09M | |
| Average Diluted Shares Outstanding | 21.08M | 4.59M | 4.30M | 4.09M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |